Gossamer Bio, Inc. (GOSS) Q2 2024 Earnings
GOSS·Reported August 12, 2024·Before market open
Gossamer Bio, Inc. reported Q2 2024 revenue of $95.8M, missed analyst consensus of $114.3M by $18.4M. Diluted EPS came in at $0.22, missed the $0.23 consensus by $0.01.
Revenue
$95.8Mmissed by $18.4M
Consensus: $114.3MDiluted EPS
$0.22missed by $0.01
Consensus: $0.23
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Gossamer Bio, Inc.'s Q2 2024 earnings report.
Gossamer Bio, Inc. (GOSS) reported Q2 2024 earnings on August 12, 2024 before market open.
Gossamer Bio, Inc. reported revenue of $95.8M and diluted EPS of $0.22 for Q2 2024.
Revenue missed the consensus estimate of $114.3M by $18.4M. EPS missed the consensus estimate of $0.23 by $0.01.
You can read the 10-Q periodic report (0001728117-24-000085) directly on SEC EDGAR. The filing index links above go to sec.gov.